NextFin News -
Pre-Market Performance
U.S. equity futures point to a firmer open, with risk appetite supported by easing oil prices and a pullback in Treasury yields from multi-decade highs. Dow futures rose 360 points, or 0.70%, to 51,918; Nasdaq 100 futures gained 198.0 points, or 0.63%, to 31,515.8; and S&P 500 futures advanced 39.0 points, or 0.50%, to 7,865.3.
European equities were also higher. The FTSE 100 rose 33.87 points, or 0.32%, to 10,531.81, with an intraday range of 10,498.03–10,602.57. France's CAC 40 gained 44.62 points, or 0.57%, to 7,878.72, while Germany's DAX climbed 178.03 points, or 0.70%, to 25,432.24.
In commodities and currencies, energy prices retreated: NYMEX crude fell $1.77 to $87.66, while Brent crude declined $1.82 to $98.50. Gold rose $26.00 to $4,182.80. The euro strengthened 0.0021 to 1.1244 against the dollar, while the yen traded around 158.20; the U.S. dollar index was modestly firmer, up about 0.1% earlier in the session.
Hot News
- Futures rebound as oil and yields ease. U.S. stock futures advanced as crude prices slipped and Treasury yields backed away from recent highs. Reuters reported that the 30-year Treasury yield eased after touching its highest level since 2002, helping growth and AI-linked shares stabilize ahead of the next earnings season.
- Oil retreat reduces pressure on inflation-sensitive trades. Crude prices fell as Middle Eastern exports improved and G7 emergency stockpile measures helped ease supply fears, though geopolitical risk remains elevated. Brent moved back below the $100 level in early U.S. trading, providing relief to transportation, consumer and rate-sensitive sectors.
- AI power demand keeps nuclear energy in focus. Google parent Alphabet is reportedly nearing a multiyear agreement worth $1 billion or more to buy nuclear power from Constellation Energy. The potential deal underscores a broader market theme: large technology companies are moving aggressively to secure reliable electricity for AI data centers.
- Global equity tone remains constructive. Gains in the DAX, CAC 40 and FTSE 100 suggest broad support for risk assets. Investors are balancing higher-rate concerns against resilient earnings expectations and continued demand for AI infrastructure.
- Earnings season approaches with elevated expectations. Market attention is shifting toward upcoming corporate results, with analysts expecting AI-linked earnings strength to offset pressure from higher financing costs and volatile energy prices.
U.S. Stock Focus
- Option Care Health — Shares jump on takeover report. Option Care Health surged 23.8% to $28.94 in pre-market trading after reports said McKesson and Clayton, Dubilier & Rice were nearing a deal to acquire the infusion-services provider. The transaction was described as valued at about $5 billion or more including debt.
- Constellation Energy — Nuclear-power talks lift sentiment. Constellation Energy rose in pre-market trading on reports of the potential Google nuclear-power purchase agreement, adding to investor focus on nuclear operators as AI data-center electricity demand accelerates.
- Alphabet — Google pursues additional AI power supply. Alphabet's Google is reportedly in advanced talks for the Constellation deal, highlighting how AI infrastructure build-outs are becoming a material operating and capital-allocation issue for megacap technology companies.
- Nvidia — AI leadership keeps shares firm. Nvidia rose about 0.7% in pre-market trading, with its market value reported near $5.8 trillion. The stock remains a central driver of the AI trade after the Nasdaq closed at a record high on Monday, supported by strength in Nvidia and Microsoft.
- Microsoft — Melius upgrade supports pre-market interest. Microsoft drew attention after Melius Research upgraded the stock to Buy and set a $665 price target. The firm cited rising enterprise demand for AI security, governance and model-routing infrastructure as potential growth drivers.
- Oracle — Voluntary separation reports watched by investors. Oracle traded slightly higher overnight after reports circulated about a possible expanded voluntary separation program for some U.S. employees. The reports have not been confirmed by the company, but investors are watching for signs of further cost discipline after Oracle's prior restructuring activity.
- Intel — Shares pressured by Terafab and market-share concerns. Intel was among notable pre-market decliners, with Investing.com showing the stock down about 3.48%. The weakness followed reports that TSMC is exploring a potential collaboration with Elon Musk's Terafab project, raising questions about Intel's previously highlighted manufacturing role.
- Nike — Revenue miss weighs on shares. Nike fell about 3% after hours after a mixed fiscal first-quarter report. Earnings beat expectations, but revenue weakness and pressure in China kept investors cautious on the athletic-apparel maker's near-term recovery path.
- Vaxcyte — Stock slips after financing plans. Vaxcyte fell about 3.8% in pre-market trading after a sharp rally on Monday tied to topline Phase 3 OPUS-1 adult trial results. The company also announced underwritten offerings of $500 million of common stock and pre-funded warrants, plus $500 million of convertible senior notes due 2032.
- Constellation Brands — Earnings due after the close. Constellation Brands is scheduled to report results after the market close, with consensus expectations listed at about $3.61 in EPS and $2.54 billion in revenue. Investors will focus on beer demand, margin trends and any update to full-year guidance.
更多独家洞察尽在 nextfin.ai.
